ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab Biosimilar

Clinical trial NCT07425639 · RECRUITING

Trial details

NCT number: NCT07425639
Sponsor: Celltrion HealthCare France
Status: RECRUITING
Study type: OBSERVATIONAL

Chronic Spontaneous Urticaria (CSU)Allergic Asthma

Start date: 2025-10-02
Primary completion: 2028-03-01
Enrollment: 225

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.